Lewis William's Form 4 filing
INSMED Inc (INSM) · filed Jan 10, 2025
- Accession no.
- 0001628280-25-001203
- Filed
- Jan 10, 2025
- Trade date
- Jan 7-10, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $995.0K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lewis WilliamCIK 0001402051 | Director, Officer (Chair and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2025 | Common Stock | SSaleDisposed | −8,218 | $66.02F2 | −$542,552.36 | 376,742 | Direct | |
| Jan 8, 2025 | Common Stock | SSaleDisposed | −3,999 | $65.96 | −$263,774.04 | 372,743 | Direct | |
| Jan 8, 2025 | Common Stock | AGrant or awardAcquired | +22,824 | –F4 | – | 395,567 | Direct | |
| Jan 10, 2025 | Common Stock | SSaleDisposed | −2,978 | $63.36 | −$188,686.08 | 392,589 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 8, 2025 | Common Stock | AGrant or awardAcquired | +109,490 | $0.00 | $0 | 109,490 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This is the weighted average sales price representing 8,218 shares sold at prices ranging from $66.00 to $66.05 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F4
Each RSU was granted on January 8, 2025 for no consideration.
Referenced by the price of 1 transaction in Table I.